Invention Grant
US09321809B2 Macrocyclic compounds for suppressing replication of hepatitis C virus
有权
用于抑制丙型肝炎病毒复制的大环化合物
- Patent Title: Macrocyclic compounds for suppressing replication of hepatitis C virus
- Patent Title (中): 用于抑制丙型肝炎病毒复制的大环化合物
-
Application No.: US14375418Application Date: 2012-12-05
-
Publication No.: US09321809B2Publication Date: 2016-04-26
- Inventor: Ben Li , Li Chen , Peibing Zhai , Tao Jiang
- Applicant: Ginkgo Pharma Co., Ltd.
- Applicant Address: CN Suzhou
- Assignee: GINKGO PHARAMA CO., LTD.
- Current Assignee: GINKGO PHARAMA CO., LTD.
- Current Assignee Address: CN Suzhou
- Agency: Greenberg Traurig, LLP
- Agent Weisun Rao
- Priority: CN201210034872 20120216
- International Application: PCT/CN2012/085912 WO 20121205
- International Announcement: WO2013/120371 WO 20130822
- Main IPC: C07K5/12
- IPC: C07K5/12 ; C07K5/103 ; C07K5/087 ; C07K5/083 ; A61K38/07 ; A61K38/08 ; A61K45/06 ; C07K7/06 ; A61K38/00 ; A61K38/55 ; C07K5/065 ; C07K5/062
Abstract:
A compound as represented by Formula (I) is provided, wherein groups are defined in the description. The compound is used as HCV protease inhibitor for treating HCV infection.
Public/Granted literature
- US20150031603A1 MACROCYCLIC COMPOUNDS FOR SUPPRESSING REPLICATION OF HEPATITIS C VIRUS Public/Granted day:2015-01-29
Information query
